Information about Femigin / DAC Pharma Holding
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
Code Description
{{activiteit.code}} {{activiteit.description}}

Femigin / DAC Pharma Holding (SRL)

50048139

Rijksweg 11, 7975 RS Uffelte

Company information

Status
Active

KVK number

50048139

VAT Number

Established
28-05-2010
Last balance sheet year
2023
Company size
Small 0 FTE
RSIN number
822513869
Commercial name
Femigin/DAC Pharma Holding
Principal activity
Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Femigin / DAC Pharma Holding

2023 2022 2021 2020
Equity € 4.506.619 -5 % € 4.719.620 26 % € 3.748.086 26 % € 2.963.116
Employees 0 1 1 1

Frequently asked questions

What is the VAT number of Femigin / DAC Pharma Holding?
Log in or start a free trial to view the VAT number.
What is the KVK number of Femigin / DAC Pharma Holding?
The KVK number of Femigin / DAC Pharma Holding is 50048139
When was Femigin / DAC Pharma Holding founded?
Femigin / DAC Pharma Holding was founded on 28-05-2010.
What is the address of Femigin / DAC Pharma Holding?
The current registered office of Femigin / DAC Pharma Holding is located at Rijksweg 11, 7975 RS Uffelte.
When was the last time Femigin / DAC Pharma Holding filed their annual financial statements?
The most recent financial statements of Femigin / DAC Pharma Holding were filed on 26-06-2025.
How many employees does Femigin / DAC Pharma Holding have?
There are currently no employees working at Femigin / DAC Pharma Holding or no workforce information is available.
What is the annual turnover of Femigin / DAC Pharma Holding?
There is no turnover available for Femigin / DAC Pharma Holding.

Sources